Literature DB >> 17208302

The C-terminus of complement factor H is essential for host cell protection.

Mihály Józsi1, Martin Oppermann, John D Lambris, Peter F Zipfel.   

Abstract

Complement is a powerful self-amplifying system of innate immune defense with the capacity to eliminate microbes directly. Factor H is a central regulator in plasma which protects host tissue from complement mediated damage. Here we characterize the relevance of surface attached factor H, and study the regulatory activity of factor H on endothelial cells. Although these cells expressed membrane bound regulators, cell bound factor H contributed substantially to complement regulatory activity at the cell surface. Blockade of the C-terminus of factor H with monoclonal antibodies inhibited cell binding of this soluble regulator and resulted in enhanced complement activation on the cells. In the absence of factor H, increased deposition and slower inactivation of C3b resulted in higher amount of membrane attack complexes on the cell surface. When the membrane regulators CD55 and CD59 were removed by enzymatic treatment, complement mediated cell lysis was enhanced in the absence of factor H. Importantly, inhibition of the C-terminus did not compromise the regulatory function of factor H in fluid phase. Altogether these data point to a highly relevant, yet so far underestimated role of factor H for complement control at cellular surfaces, and reveal a decisive role of the factor H C-terminus in host cell recognition and protection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17208302      PMCID: PMC2700862          DOI: 10.1016/j.molimm.2006.12.001

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  49 in total

Review 1.  Complement. First of two parts.

Authors:  M J Walport
Journal:  N Engl J Med       Date:  2001-04-05       Impact factor: 91.245

2.  Each of the three binding sites on complement factor H interacts with a distinct site on C3b.

Authors:  T S Jokiranta; J Hellwage; V Koistinen; P F Zipfel; S Meri
Journal:  J Biol Chem       Date:  2000-09-08       Impact factor: 5.157

3.  Exceptional resistance of human H2 glioblastoma cells to complement-mediated killing by expression and utilization of factor H and factor H-like protein 1.

Authors:  S Junnikkala; T S Jokiranta; M A Friese; H Jarva; P F Zipfel; S Meri
Journal:  J Immunol       Date:  2000-06-01       Impact factor: 5.422

4.  The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20.

Authors:  Jessica Caprioli; Paola Bettinaglio; Peter F Zipfel; Barbara Amadei; Erica Daina; Sara Gamba; Christine Skerka; Nicola Marziliano; Giuseppe Remuzzi; Marina Noris
Journal:  J Am Soc Nephrol       Date:  2001-02       Impact factor: 10.121

5.  Calcein-acetyoxymethyl cytotoxicity assay: standardization of a method allowing additional analyses on recovered effector cells and supernatants.

Authors:  S Neri; E Mariani; A Meneghetti; L Cattini; A Facchini
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

6.  Molecular modelling of the C-terminal domains of factor H of human complement: a correlation between haemolytic uraemic syndrome and a predicted heparin binding site.

Authors:  Stephen J Perkins; Timothy H J Goodship
Journal:  J Mol Biol       Date:  2002-02-15       Impact factor: 5.469

7.  Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome.

Authors:  D Pérez-Caballero; C González-Rubio; M E Gallardo; M Vera; M López-Trascasa; S Rodríguez de Córdoba; P Sánchez-Corral
Journal:  Am J Hum Genet       Date:  2001-01-17       Impact factor: 11.025

8.  Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition.

Authors:  A Richards; M R Buddles; R L Donne; B S Kaplan; E Kirk; M C Venning; C L Tielemans; J A Goodship; T H Goodship
Journal:  Am J Hum Genet       Date:  2001-01-17       Impact factor: 11.025

9.  Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces.

Authors:  Viviana P Ferreira; Andrew P Herbert; Henry G Hocking; Paul N Barlow; Michael K Pangburn
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

10.  C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity.

Authors:  D Gershov; S Kim; N Brot; K B Elkon
Journal:  J Exp Med       Date:  2000-11-06       Impact factor: 14.307

View more
  41 in total

Review 1.  Complement control protein factor H: the good, the bad, and the inadequate.

Authors:  Viviana P Ferreira; Michael K Pangburn; Claudio Cortés
Journal:  Mol Immunol       Date:  2010-08       Impact factor: 4.407

2.  Potentiation of complement regulator factor H protects human endothelial cells from complement attack in aHUS sera.

Authors:  Richard B Pouw; Mieke C Brouwer; Marlon de Gast; Anna E van Beek; Lambertus P van den Heuvel; Christoph Q Schmidt; Arie van der Ende; Pilar Sánchez-Corral; Taco W Kuijpers; Diana Wouters
Journal:  Blood Adv       Date:  2019-02-26

Review 3.  Review: Complement and its regulatory proteins in kidney diseases.

Authors:  Allison M Lesher; Wen-Chao Song
Journal:  Nephrology (Carlton)       Date:  2010-10       Impact factor: 2.506

4.  Borrelia burgdorferi lacking DbpBA exhibits an early survival defect during experimental infection.

Authors:  Eric H Weening; Nikhat Parveen; Jerome P Trzeciakowski; John M Leong; Magnus Höök; Jonathan T Skare
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

Review 5.  Targeting mechanisms at sites of complement activation for imaging and therapy.

Authors:  V Michael Holers
Journal:  Immunobiology       Date:  2015-04-30       Impact factor: 3.144

Review 6.  Glomerular basement membrane heparan sulfate in health and disease: A regulator of local complement activation.

Authors:  Dorin-Bogdan Borza
Journal:  Matrix Biol       Date:  2016-09-06       Impact factor: 11.583

7.  Separation of decay-accelerating and cofactor functional activities of Kaposi's sarcoma-associated herpesvirus complement control protein using monoclonal antibodies.

Authors:  Linda Mark; David G Proctor; David J Blackbourn; Anna M Blom; O Brad Spiller
Journal:  Immunology       Date:  2007-08-30       Impact factor: 7.397

Review 8.  Biology of human pentraxin 3 (PTX3) in acute and chronic kidney disease.

Authors:  Marijn M Speeckaert; Reinhart Speeckaert; Juan J Carrero; Raymond Vanholder; Joris R Delanghe
Journal:  J Clin Immunol       Date:  2013-02-27       Impact factor: 8.317

9.  Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis.

Authors:  Allison M Lesher; Lin Zhou; Yuko Kimura; Sayaka Sato; Damodar Gullipalli; Andrew P Herbert; Paul N Barlow; Hannes U Eberhardt; Christina Skerka; Peter F Zipfel; Takayuki Hamano; Takashi Miwa; Kenneth S Tung; Wen-Chao Song
Journal:  J Am Soc Nephrol       Date:  2012-11-30       Impact factor: 10.121

10.  Factor H mediated cell surface protection from complement is critical for the survival of PNH erythrocytes.

Authors:  Viviana P Ferreira; Michael K Pangburn
Journal:  Blood       Date:  2007-06-06       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.